Medically reviewed by Leah Ansell, MD Key Takeaways Plaque psoriasis is an autoimmune condition that causes raised, red skin patches covered with white scales.While there is no cure for plaque ...

Zasocitinib, which is a potent and highly selective TYK2 inhibitor would be a good option for some of our patients who are ...

Plaque psoriasis is a long-lasting skin condition that causes thick, scaly patches (plaques) on the skin. It happens when your immune system becomes overactive and speeds up the growth of skin cells.

84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin (IGA 0/1) at Week 16 ICONIC-LEAD is the first ever Phase 3 ...

Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent ...

About Plaque Psoriasis Plaque psoriasis (PsO) is a chronic immune-mediated disease resulting in overproduction of skin cells, which causes inflamed, scaly plaques that may be itchy or painful. It is ...

ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% of ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...